Exploring public attitudes towards the new Faster Diagnosis Standard for cancer: a focus group study with the UK public

Br J Gen Pract. 2019 Jun;69(683):e413-e421. doi: 10.3399/bjgp19X702677. Epub 2019 Mar 11.

Abstract

Background: The Faster Diagnosis Standard (FDS) is to be introduced in England in 2020. This standard is a new policy in which patients should have cancer ruled out or diagnosed within 28 days of referral.

Aim: To explore public attitudes towards the FDS within the context of their recent referral experiences.

Design and setting: Four 90-minute focus groups (two in Guildford, two in Bradford).

Method: Participants aged >50 years without a current cancer diagnosis (N = 29), who had completed certain diagnostic tests, for example, ultrasound, and received results within the last 6 months were recruited. Age, education, and sex were evenly distributed across groups through purposive sampling.

Results: The largest cause of concern was the waiting process for obtaining test results. Most had experienced swift referral, and it was difficult for participants to understand how the new standard could impact upon time progressing through the system. Responsibility for meeting the standard was also a concern: participants did not see their own behaviours as a form of involvement. The GP's role was conceptualised by patients as communicating about their referral, establishing patients' preferences for information, and continued involvement at each stage of the referral process. The standard legitimised chasing for test results, but 28 days was considered too long.

Conclusion: Patients should be asked what they would like to know about their referral. GPs should be more transparent about the referral process and the potential for a lack of clarity around next steps.

Keywords: Faster Diagnosis Standard; cancer; early diagnosis; general practice; patient experience; referral and consultation.

MeSH terms

  • Aged
  • Early Detection of Cancer*
  • Female
  • Focus Groups
  • Health Policy*
  • Humans
  • Male
  • Middle Aged
  • Neoplasms / diagnosis*
  • Patient Satisfaction
  • Public Opinion*
  • Referral and Consultation*
  • Surveys and Questionnaires
  • United Kingdom